Adtrinib Tablet belongs to the class of cancer medications known as multikinase inhibitors containing the active ingredient sorafenib. It is primarily used to treat advanced renal cell carcinoma (kidney cancer), hepatocellular carcinoma (liver cancer), and thyroid cancer. Adtrinib Tablet is not recommended if you are allergic to the active compound and other ingredients of the medicine. Speak with your doctor immediately if you experience skin rashes, heart problems, chest pain, bleeding problems, high blood pressure, or have had or are about to have surgery. It is not recommended for use in children and adolescents. Patients with diabetes should have their blood sugar levels examined frequently to see whether the dosage of anti-diabetic medications needs to be changed to reduce the risk of low blood sugar. Your doctor will monitor liver function tests and fluid and electrolyte balance to help identify and manage potential side effects promptly. Very secure payment methods Shipping will be calculated on checkout Please note that price may increase due to exchange rate, ensure updated price before making payment
